Evidence map›Paper›PMID 37366907›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study.

Badria Alkazemi, Feras M Ghazawi, François Lagacé, Vladimir Nechaev, Andrei Zubarev, Ivan V Litvinov

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Trends of publications on primary sarcomas of bone: A bibliometric analysis.Journal of clinical orthopaedics and trauma · 2025
    Article
  7. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Badria AlkazemiFaculty of Medicine, University of Leeds School of Medicine, Leeds LS2 9JT, UK.
Feras M GhazawiDivision of Dermatology, University of Ottawa, Ottawa, ON K1H 8M2, Canada.
François LagacéExperimental Medicine Training Program, Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.ORCID 0000-0002-9033-2302
Vladimir NechaevIndependent Researcher, 187015 Saint Peterburg, Russia.
Andrei ZubarevCancer Research Program, McGill University Health Centre Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.
Ivan V LitvinovExperimental Medicine Training Program, Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.ORCID 0000-0003-0562-4675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomas are a heterogeneous group of mesenchymal malignancies with various genetic and environmental risk factors. This study analyzed the epidemiology of sarcomas to gain insight into the incidence and mortality rates of these cancers in Canada, as well as to elucidate their potential environmental risk factors. Data for this study were obtained from le Registre Québécois du Cancer (LRQC) and from the Canadian Cancer Registry (CCR) for the period from 1992 to 2010. Mortality data were obtained from the Canadian Vital Statistics (CVS) database for the period from 1992 to 2010 using the International Classification of Diseases for Oncology, ICD-O-3, ICD-9, or ICD-10 codes, for all subtypes of sarcomas. We found that the overall sarcoma incidence in Canada decreased during the study period. However, there were select subtypes with increasing incidence. Peripherally located sarcomas were found to have lower mortality rates compared to axially located sarcomas, as expected. Clustering of Kaposi sarcoma cases in self-identified LGBTQ+ communities and in postal codes with a higher proportion of African-Canadian and Hispanic populations was observed. Forward Sortation Area (FSA) postal codes with a lower socioeconomic status also had higher Kaposi sarcoma incidence rates.

Indexed as

SarcomaSarcoma, KaposiSoft Tissue NeoplasmsCanadaHumansIncidenceaxial sarcomabone sarcomaCanadaCanadian Cancer RegistrycancerepidemiologyincidenceKaposi sarcomamortalityperipheral sarcomapostal codesarcomasoft tissue sarcoma

Identifiers

PMID37366907
PMCPMC10297017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.